In 2023, Germany dominated the production of compounds containing a pyrimidine or piperazine ring in Europe, contributing significantly to the total volume. Sweden and Italy followed, with notable increases in output. Belgium and the Netherlands, however, showed a complete reduction in reported figures. Hungary's substantial growth contrasts with the slight declines or stagnations observed in most other countries.
Looking ahead, the European production landscape for these compounds will likely see shifts due to technological advancements, regulatory changes, and emerging markets. Countries bolstering innovation and investment in pharmaceutical manufacturing may capture increased production shares. Environmental considerations will also influence future industry dynamics.
Top countries in Production of Compounds Containing a Pyrimidine Ring or Piperazine Ring in the Structure Share by Country (Kilograms)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 79.48 | 2023 | +3.43% | +1.14% | View data |
| 2 | 2 Sweden | 9.11 | 2023 | View data | ||
| 3 | 3 Italy | 3.92 | 2023 | +4.54% | +2.33% | View data |
| 4 | 4 Belgium | 2.98 | 2023 | +16.61% | View data | |
| 5 | 5 Denmark | 1.35 | 2023 | -32.51% | View data | |
| 6 | 6 Spain | 1.19 | 2023 | +1.22% | -6.96% | View data |
| 7 | 7 France | 0.88 | 2023 | +16.09% | -1.85% | View data |
| 8 | 8 Netherlands | 0.41 | 2023 | View data | ||
| 9 | 9 Hungary | 0.29 | 2023 | -35.91% | +87.58% | View data |
| 10 | 10 United Kingdom | 0.27 | 2023 | -24.75% | View data |
